! ORL via Alexandros G.Sfakianakis on Inoreader: Laryngeal Side Effects of Tyrosine Kinase Inhibitors

! ORL via Alexandros G.Sfakianakis on Inoreader

Laryngeal Side Effects of Tyrosine Kinase Inhibitors Aug 11th 2015, 00:51, by Sharon Ovnat Tamir, Dafna Gershnabel Milk, Yehudah Roth, Udi Cinamon, Asher Winder, Ronen Brenner, Ariel Katz, Tal Marom Tyrosine kinase inhibitors (TKIs) are common targeted drugs, used in the treatment of hematological and solid malignancies. These drugs present a multitude of potential adverse effects. Laryngeal manifestations, including laryngeal edema, secondary to TKIs treatment have not been well studied, despite their potential lethality.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions